With two provinces at various stages of drug pricing reforms, proactive employers might see little or no price inflation in their drug plans over the next two to three years. Alberta has tabled proposed changes to generic drug pricing and discussions are underway in Ontario. Depending on the approach eventually taken, other parts of the […]